SAM
AMED

Shell Asset Management’s Amedisys AMED Stock Holding History

Shell Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-710
Closed -$70K – 1151
2025
Q2 		$70K Sell
710
-78
-10% -$7.38K ﹤0.01% 1078
2025
Q1 		$73K Sell
788
-34
-4% -$3.13K ﹤0.01% 1075
2024
Q4 		$75K Hold
822
– – ﹤0.01% 1098
2024
Q3 		$79K Buy
+822
New +$80.2K ﹤0.01% 1097
2024
Q1 		$80K Sell
871
-99
-10% -$9.28K ﹤0.01% 1076
2023
Q4 		$92K Sell
970
-290
-23% -$27.1K ﹤0.01% 1081
2023
Q3 		$118K Sell
1,260
-20
-2% -$1.85K ﹤0.01% 1048
2023
Q2 		$117K Sell
1,280
-7
-0.5% -$574 ﹤0.01% 1086
2023
Q1 		$95K Sell
1,287
-5
-0.4% -$433 ﹤0.01% 1112
2022
Q4 		$108K Sell
1,292
-262
-17% -$23.6K ﹤0.01% 1134
2022
Q3 		$150K Sell
1,554
-408
-21% -$48.7K 0.01% 1105
2022
Q2 		$206K Buy
1,962
+4
+0.2% +$511 0.01% 1112
2022
Q1 		$337K Sell
1,958
-289
-13% -$43.2K 0.01% 997
2021
Q4 		$364K Buy
2,247
+7
+0.3% +$1.13K 0.01% 1033
2021
Q3 		$334K Sell
2,240
-90
-4% -$18.7K 0.01% 1037
2021
Q2 		$571K Buy
2,330
+1,712
+277% +$449K 0.01% 854
2021
Q1 		$164K Hold
618
– – ﹤0.01% 1192
2020
Q4 		$181K Hold
618
– – ﹤0.01% 1145
2020
Q3 		$146K Hold
618
– – ﹤0.01% 1106
2020
Q2 		$123K Buy
+618
New +$115K ﹤0.01% 1125

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Shell Asset Management's AMED Position: Q3 2025 in Review

Shell Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 710 shares — an estimated $70K sold.

Shell Asset Management first reported a position in AMED in Q2 2020 and held it in 20 quarters. The position peaked at $571K in Q2 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Shell Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Shell Asset Management sold 710 Amedisys shares in Q3 2025, an estimated $70K.
  • Shell Asset Management first reported a position in Amedisys in Q2 2020 and held it in 20 quarters.
  • Shell Asset Management's Amedisys position peaked at $571K in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.